EG14984A - Controlled release compositions - Google Patents

Controlled release compositions

Info

Publication number
EG14984A
EG14984A EG80785A EG78580A EG14984A EG 14984 A EG14984 A EG 14984A EG 80785 A EG80785 A EG 80785A EG 78580 A EG78580 A EG 78580A EG 14984 A EG14984 A EG 14984A
Authority
EG
Egypt
Prior art keywords
controlled release
release compositions
compositions
controlled
release
Prior art date
Application number
EG80785A
Other languages
English (en)
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of EG14984A publication Critical patent/EG14984A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/05Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
EG80785A 1979-12-19 1980-12-20 Controlled release compositions EG14984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19

Publications (1)

Publication Number Publication Date
EG14984A true EG14984A (en) 1986-06-30

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
EG80785A EG14984A (en) 1979-12-19 1980-12-20 Controlled release compositions

Country Status (27)

Country Link
US (1) US4366310A (el)
EP (1) EP0032004B1 (el)
JP (1) JPS5698201A (el)
AU (1) AU541246B2 (el)
BE (1) BE886711A (el)
CA (1) CA1168230A (el)
CS (1) CS228142B2 (el)
DE (1) DE3048028A1 (el)
DK (1) DK170347B1 (el)
EG (1) EG14984A (el)
ES (1) ES497906A0 (el)
FI (1) FI66623C (el)
FR (1) FR2474507B1 (el)
GB (1) GB2067569B (el)
GR (1) GR72265B (el)
HU (1) HU188085B (el)
IE (1) IE49324B1 (el)
IL (1) IL61677A (el)
MX (1) MX158088A (el)
NL (1) NL187401C (el)
NO (1) NO152846C (el)
NZ (1) NZ195793A (el)
PL (1) PL133079B1 (el)
PT (1) PT72214B (el)
SU (1) SU1178326A3 (el)
YU (1) YU40957B (el)
ZA (1) ZA807716B (el)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
DK1685839T3 (da) 1997-12-22 2013-06-24 Euro Celtique Sa Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
AU776666B2 (en) 2000-02-08 2004-09-16 Euro-Celtique S.A. Tamper-resistant oral opioid agonist formulations
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
US7943173B2 (en) 2001-07-18 2011-05-17 Purdue Pharma L.P. Pharmaceutical combinations of oxycodone and naloxone
WO2003013525A1 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
CA2478515C (en) 2002-04-05 2010-09-28 Purdue Pharma Pharmaceutical preparation containing oxycodone and naloxone
DK1551372T3 (en) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1765292B1 (en) 2004-06-12 2017-10-04 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
KR101486228B1 (ko) 2006-06-19 2015-01-26 알파마 파머슈티컬스 엘엘씨 약제학적 조성물
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
WO2010103039A1 (en) 2009-03-10 2010-09-16 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2011141490A1 (en) 2010-05-10 2011-11-17 Euro-Celtique S.A. Combination of active loaded granules with additional actives
NZ603173A (en) 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
KR20130030260A (ko) 2010-05-10 2013-03-26 유로-셀티큐 에스.에이. 히드로모르폰 및 날록손을 포함하는 제약 조성물
EP2826467B1 (en) 2010-12-22 2017-08-02 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
PH12013501345A1 (en) 2010-12-23 2022-10-24 Purdue Pharma Lp Tamper resistant solid oral dosage forms
CN105120846B (zh) 2013-02-05 2019-10-18 普渡制药公司 抗篡改的药物制剂
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
KR20180037074A (ko) 2013-07-23 2018-04-10 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
WO2017222575A1 (en) 2016-06-23 2017-12-28 Collegium Pharmaceutical, Inc. Process of making more stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
PT72214A (en) 1980-08-01
FI803848L (fi) 1981-06-20
FR2474507A1 (fr) 1981-07-31
FI66623C (fi) 1984-11-12
HUT34891A (en) 1985-05-28
SU1178326A3 (ru) 1985-09-07
AU6529880A (en) 1981-06-25
US4366310A (en) 1982-12-28
PL133079B1 (en) 1985-05-31
NL187401C (nl) 1991-09-16
BE886711A (fr) 1981-06-17
NO803836L (no) 1981-06-22
IL61677A (en) 1984-10-31
DK170347B1 (da) 1995-08-07
GB2067569A (en) 1981-07-30
EP0032004A2 (en) 1981-07-15
AU541246B2 (en) 1985-01-03
JPH0225921B2 (el) 1990-06-06
CS228142B2 (en) 1984-05-14
ZA807716B (en) 1981-12-30
PT72214B (en) 1981-11-02
IE49324B1 (en) 1985-09-18
EP0032004B1 (en) 1985-05-15
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
EP0032004A3 (en) 1982-07-14
GB2067569B (en) 1983-09-01
JPS5698201A (en) 1981-08-07
NL187401B (nl) 1991-04-16
CA1168230A (en) 1984-05-29
NO152846C (no) 1985-11-27
ES8303489A1 (es) 1983-02-01
IE792480L (en) 1981-06-19
HU188085B (en) 1986-03-28
NL8006891A (nl) 1981-07-16
FI66623B (fi) 1984-07-31
ES497906A0 (es) 1983-02-01
IL61677A0 (en) 1981-01-30
PL228573A1 (el) 1982-07-19
DE3048028A1 (de) 1981-09-10
YU40957B (en) 1986-08-31
FR2474507B1 (fr) 1986-12-26
GR72265B (el) 1983-10-10
YU321080A (en) 1983-06-30
DK527680A (da) 1981-08-05
NO152846B (no) 1985-08-19

Similar Documents

Publication Publication Date Title
GB2067569B (en) Controlled release compositions
GB2056278B (en) Sustained release compositions
GB2059764B (en) Controlled release formulations
GB2046283B (en) Soloxane composition
JPS565899A (en) Claning composition
JPS5634751A (en) Polycarbonateepolyolefin composition
JPS55129447A (en) Composition
JPS5682839A (en) Waterrabsorbable composition
GB2059766B (en) Controlled release formulations
EG15103A (en) Oxytetrocycline compositions
IE800872L (en) Tickicidal compositions
JPS5691075A (en) Size composition
GB2063348B (en) Release mechanism
JPS5622734A (en) Composition
JPS5649747A (en) Ureaaformaldehyde composition
JPS56135531A (en) Composition
JPS55118957A (en) Flameeproof composition
GB2058034B (en) Fluocculant composition
ZA805153B (en) Schistosomididal compositions
ZA803634B (en) Water-settable compositions
GB2062462B (en) Compositions phthalazinol
JPS55157694A (en) Clensing composition
JPS5655393A (en) Hydrocarbonnsoluble magnesiummaluminum composition
EG14325A (en) Pesticidel compositions
ZA801365B (en) Controlled release graunules